The prevalence of corporate funding in adult lower extremity research and its correlation with reported results

J Arthroplasty. 2003 Oct;18(7 Suppl 1):138-45. doi: 10.1016/s0883-5403(03)00289-4.

Abstract

The author reviewed 603 consecutive articles and scientific presentations pertaining to adult lower extremity orthopedic research from 2 major American orthopedic journals and 2 major American orthopedic meetings. The prevalence of commercial funding in these studies was 50%. Clinical studies of total hip arthroplasty implants by American investigators were commercially sponsored in 75% of studies. Commercially funded hip research reported positive outcomes in 93% of studies, whereas independently funded researchers reported good results in only 37%. Funded clinical studies of total knee arthroplasty implants yielded good results in 75%; this is in contrast to the findings of independently funded investigators, who reported positive conclusions in only 20% of studies. Investigators receiving royalties reported no negative outcomes related to the respective devices. The source of research funding was strongly correlated with reported outcomes.

MeSH terms

  • Adult
  • Arthroplasty, Replacement, Hip
  • Arthroplasty, Replacement, Knee
  • Disclosure / statistics & numerical data
  • Humans
  • Orthopedics / economics*
  • Outcome Assessment, Health Care / economics*
  • Periodicals as Topic / statistics & numerical data
  • Research Support as Topic / statistics & numerical data*
  • United States